TRAIL of Hope Meeting Resistance in Cancer

被引：114
作者：
Deng, David [1 ,2 ]
Shah, Khalid [1 ,2 ,3 ]
机构：
[1] Harvard Med Sch, Ctr Stem Cell Therapeut & Imaging, Brigham & Womens Hosp, Boston, MA 02129 USA
[2] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02129 USA
[3] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA
来源：
TRENDS IN CANCER | 2020年 / 6卷 / 12期
基金：
美国国家卫生研究院;
关键词：
RECEPTOR-SELECTIVE MUTANTS; INDUCED APOPTOSIS; TUMORICIDAL ACTIVITY; DEATH RECEPTORS; DOWN-REGULATION; SURFACE EXPRESSION; ANTITUMOR EFFICACY; MELANOMA CELLS; CROSS-LINKING; TNF-ALPHA;
D O I：
10.1016/j.trecan.2020.06.006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) induces apoptosis selectively via its interaction with the death receptors TRAILR1/DR4 and TRAILR2/DR5 in a wide range of cancers, while sparing normal cells. Despite its tremendous potential for cancer therapeutics, the translation of TRAIL into the clinic has been confounded by TRAIL-resistant cancer populations. We discuss different molecular mechanisms underlying TRAIL-mediated apoptosis and resistance to TRAIL. We also discuss the successes and failures of recent preclinical and clinical studies of TRAIL-induced apoptosis, and current attempts to overcome TRAIL resistance, and we provide a perspective for improving the prospects of future clinical implementation.
引用
收藏
页码：989 / 1001
页数：13
相关论文
共 91 条
[1]   Targeting TRAIL Death Receptor 4 with Trivalent DR4 Atrimer Complexes [J].
Allen, Joshua E. ;
Ferrini, Roger ;
Dicker, David T. ;
Batzer, Glenda ;
Chen, Elise ;
Oltean, Daniela I. ;
Lin, Bing ;
Renshaw, Mark W. ;
Kretz-Rommel, Anke ;
El-Deiry, Wafik S. .
MOLECULAR CANCER THERAPEUTICS, 2012, 11 (10) :2087-2095
[2]   Safety and antitumor activity of recombinant soluble Apo2 ligand [J].
Ashkenazi, A ;
Pai, RC ;
Fong, S ;
Leung, S ;
Lawrence, DA ;
Masters, SA ;
Blackie, C ;
Chang, L ;
McMurtrey, AE ;
Hebert, A ;
DeForge, L ;
Koumenis, IL ;
Lewis, D ;
Harris, L ;
Bussiere, J ;
Koeppen, H ;
Shahrokh, Z ;
Schwall, RH .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (02) :155-162
[3]   Kinome profiling of non-canonical TRAIL signaling reveals RIP1-Src-STAT3-dependent invasion in resistant non-small cell lung cancer cells [J].
Azijli, Kaamar ;
Yuvaraj, Saravanan ;
Peppelenbosch, Maikel P. ;
Wurdinger, Thomas ;
Dekker, Henk ;
Joore, Jos ;
van Dijk, Evert ;
Quax, Wim J. ;
Peters, Godefridus J. ;
de Jong, Steven ;
Kruyt, Frank A. E. .
JOURNAL OF CELL SCIENCE, 2012, 125 (19) :4651-4661
[4]  
Belch A, 2010, Blood, V116, P5031, DOI DOI 10.1182/BLOOD.V116.21.5031.5031
[5]   A20 Ubiquitin Ligase-Mediated Polyubiquitination of RIP1 Inhibits Caspase-8 Cleavage and TRAIL-Induced Apoptosis in Glioblastoma [J].
Bellail, Anita C. ;
Olson, Jeffrey J. ;
Yang, Xiaolu ;
Chen, Zhijian J. ;
Hao, Chunhai .
CANCER DISCOVERY, 2012, 2 (02) :140-155
[6]   PTEN regulates glioblastoma oncogenesis through chromatin-associated complexes of DAXX and histone H3.3 [J].
Benitez, Jorge A. ;
Ma, Jianhui ;
D'Antonio, Matteo ;
Boyer, Antonia ;
Camargo, Maria Fernanda ;
Zanca, Ciro ;
Kelly, Stephen ;
Khodadadi-Jamayran, Alireza ;
Jameson, Nathan M. ;
Andersen, Michael ;
Miletic, Hrvoje ;
Saberi, Shahram ;
Frazer, Kelly A. ;
Cavenee, Webster K. ;
Furnari, Frank B. .
NATURE COMMUNICATIONS, 2017, 8
[7]   Interactions of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) with the Immune System: Implications for Inflammation and Cancer [J].
Beyer, Katharina ;
Baukloh, Ann-Kathrin ;
Stoyanova, Ani ;
Kamphues, Carsten ;
Sattler, Arne ;
Kotsch, Katja .
CANCERS, 2019, 11 (08)
[8]   A cell-based high-throughput screen to identify synergistic TRAIL sensitizers [J].
Booth, Nancy Lynn ;
Sayers, Thomas J. ;
Brooks, Alan D. ;
Thomas, Cheryl L. ;
Jacobsen, Kristen ;
Goncharova, Ekaterina I. ;
McMahon, James B. ;
Henrich, Curtis J. .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2009, 58 (08) :1229-1244
[9]   Dulanermin with rituximab in patients with relapsed indolent B-cell lymphoma: an open-label phase 1b/2 randomised study [J].
Cheah, Chan Yoon ;
Belada, David ;
Fanale, Michelle A. ;
Janikova, Andrea ;
Czucman, Myron S. ;
Flinn, Ian W. ;
Kapp, Amy V. ;
Ashkenazi, Avi ;
Kelley, Sean ;
Bray, Gordon L. ;
Holden, Scott ;
Seymour, John F. .
LANCET HAEMATOLOGY, 2015, 2 (04) :E166-E174
[10]   Antiangiogenic Variant of TSP-1 Targets Tumor Cells in Glioblastomas (Publication with Expression of Concern. See vol. 32, pg. 1595, 2024) [J].
Choi, Sung Hugh ;
Tamura, Kaoru ;
Khajuria, Rajiv Kumar ;
Bhere, Deepak ;
Nesterenko, Irina ;
Lawler, Jack ;
Shah, Khalid .
MOLECULAR THERAPY, 2015, 23 (02) :235-243
12345678910